ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Britol-Meyers Holds Taxol Briefings, Outlines Timetable

July 5, 1991

BCF Members Miffed When NCI Refuses To Delay New Breast Cancer RFA To Allow Them Chance To Study It

April 8, 1983

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012

Cancer Meetings Listed

March 26, 1993

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982

Melanoma Cancer Vaccine Tested By Cooperative Group

August 29, 2003